Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from IDT Australia Limited ( (AU:IDT) ) is now available.
IDT Australia Limited announced the cessation of 131,428 performance rights due to unmet conditions, effective February 28, 2025. This development may impact the company’s operational strategies and stakeholder interests, as it reflects on the company’s performance metrics and future incentive structures.
More about IDT Australia Limited
IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its expertise in drug formulation and production, serving both local and international markets.
YTD Price Performance: -9.09%
Average Trading Volume: 173,842
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$41.35M
Find detailed analytics on IDT stock on TipRanks’ Stock Analysis page.